The main healthcare UCITS ETFs compared
| ETF | ISIN | Index | TER p.a. | Distribution |
|---|---|---|---|---|
| Xtrackers MSCI World Health Care 1C | IE00BM67HK77 | MSCI World Health Care | ~0.25% | accumulating |
| iShares MSCI World Health Care Sector Advanced (Dist) | IE00BJ5JNZ06 | MSCI World HC Advanced Select (ESG screen) | ~0.18% | distributing |
| Xtrackers MSCI Europe Health Care 1C | LU0292103222 | MSCI Europe Health Care | ~0.17% | accumulating |
Verification as of June 2026. TER/share classes can change — check the current KID before buying.
How to pick the right one
- World vs. Europe: the MSCI World Health Care ETFs are global and hold the US heavyweights (J&J, Eli Lilly, UnitedHealth & co.). The Europe ETF is narrower.
- Cost: all three are cheap (0.17–0.25%). The iShares Advanced is particularly low at ~0.18% for world exposure — with an ESG screen.
- Distribution: for income the distributing iShares Advanced; for wealth building the accumulating Xtrackers.
- Sector breadth: "Health Care" covers more than pure pharma — biotech, medtech and services too. That makes the ETF more robust against any single drugmaker's patent cliff.
FAQ
What is the best pharma ETF for European investors?
For broad, cheap world exposure the Xtrackers MSCI World Health Care (IE00BM67HK77, ~0.25%, accumulating). For distributions the iShares MSCI World Health Care Advanced (IE00BJ5JNZ06, ~0.18%, distributing).
Why an ETF instead of single stocks?
The biggest pharma risk is the patent cliff. An ETF bundles many companies — if one drops out, the others carry. You spread exactly the risk that hits single stocks hardest.
Pharma ETF or broad healthcare ETF?
Most ETFs track the whole healthcare sector (pharma, biotech, medtech) — broader and more robust than pure pharma. An MSCI World Health Care ETF also covers J&J, for instance.